BEAUTY HEALTH CO/THE (SKIN)
US88331L1089 - Common Stock
ChartMill assigns a Buy % Consensus number of 54% to SKIN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.65. This target is 39.75% above the current price.
SKIN was analyzed by 18 analysts. The buy percentage consensus is at 54. So analysts seem to be rather neutral about SKIN.
In the previous month the buy percentage consensus was at a similar level.
SKIN was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-15 | DA Davidson | Maintains | Buy -> Buy |
| 2024-03-14 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2024-03-13 | TD Cowen | Maintains | Market Perform -> Market Perform |
| 2024-03-13 | Stifel | Reiterate | Hold -> Hold |
| 2024-03-13 | Piper Sandler | Reiterate | Underweight -> Underweight |
| 2024-02-29 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2023-11-15 | Jefferies | Downgrade | Buy -> Hold |
| 2023-11-14 | TD Cowen | Downgrade | Outperform -> Market Perform |
| 2023-11-14 | William Blair | Downgrade | Outperform -> Market Perform |
| 2023-11-14 | Benchmark | Downgrade | Buy -> Hold |
| 2023-11-14 | Stifel | Maintains | Hold -> Hold |
| 2023-11-14 | Raymond James | Downgrade | Market Perform -> Underperform |
| 2023-11-14 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2023-11-14 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2023-11-14 | Piper Sandler | Downgrade | Overweight -> Underweight |
| 2023-09-13 | Benchmark | Reiterate | Buy -> Buy |
| 2023-08-10 | TD Cowen | Maintains | Outperform -> Outperform |
| 2023-08-10 | DA Davidson | Maintains | Buy -> Buy |
| 2023-08-08 | Benchmark | Reiterate | Buy -> Buy |
| 2023-06-21 | Stifel | Downgrade | Buy -> Hold |
| 2023-05-26 | JP Morgan | Maintains | Neutral -> Neutral |
| 2023-05-18 | Benchmark | Reiterate | Buy -> Buy |
| 2023-05-11 | DA Davidson | Reiterate | Buy |
| 2023-03-28 | Canaccord Genuity | Reiterate | Buy |
| 2023-03-20 | Exane BNP Paribas | Upgrade | Underperform -> Neutral |
| 2023-03-14 | Benchmark | Reiterate | Buy |
| 2023-03-01 | DA Davidson | Maintains | Buy |
| 2023-02-28 | Benchmark | Reiterate | Buy |
| 2023-02-16 | Cowen & Co. | Maintains | Outperform |
| 2022-11-23 | Goldman Sachs | Maintains | Buy |